Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 10/20 | 1.00 |
| ▸ | EDNRB | P24530 | 7/20 | 0.70 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7850007 | 0.84 | EDNRA (0.81) | EDNRAEDNRBMEN1KMT2ACYP2C9 | |
| SCHEMBL7716850 | 0.83 | EDNRA (1.00) | EDNRAEDNRBMEN1KMT2ACYP2C9 | |
| SCHEMBL9063597 | 0.81 | EDNRA (0.77) | EDNRAEDNRBMEN1KMT2ACYP2C9 | |
| SCHEMBL6152009 | 0.81 | EDNRA (1.00) | EDNRAEDNRBMEN1KMT2ACYP2C9 | |
| SCHEMBL15010361 | 0.80 | EDNRA (0.66) | EDNRAEDNRB | |
| SCHEMBL7858811 | 0.78 | EDNRA (0.77) | EDNRAEDNRBMEN1KMT2ACYP2C9 | |
| SCHEMBL12262674 | 0.77 | ALDH1A1 (0.85) | EDNRAMEN1KMT2ACYP2C9TSHR | |
| SCHEMBL7949548 | 0.77 | EDNRA (0.66) | EDNRAEDNRB | |
| SCHEMBL7856711 | 0.75 | EDNRA (1.00) | EDNRAEDNRBMEN1KMT2ACYP2C9 | |
| Sulfisoxazole SCHEMBL788644 | 0.75 | EDNRA (1.00) | EDNRAEDNRBMEN1KMT2ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1069114-A2 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 2001-01-17 | — | — | EP | disclosed |
| EP-0870764-A1 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-10-14 | — | — | EP | disclosed |
| US-5571821-A | CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-11-05 | — | — | US | disclosed |
| EP-0699191-A1 | SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027979-A1 | SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | IMMUNOPHARMACEUTICS, INC. (US) | 1994-12-08 | — | — | WO | disclosed |